KL-50 in post TMZ MMR-deficient GBM Podcast Por  arte de portada

KL-50 in post TMZ MMR-deficient GBM

KL-50 in post TMZ MMR-deficient GBM

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.

adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones